Clinical evaluation of Qillat tams and its Management with Unani formulation

Qillat tams refers to a spectrum of conditions varying from scanty flow to menstruation occurring at interval of more than 2 months. 1-2% of non pregnant women will have absent or infrequent periods. In addition to the potential infertility problems and the concern provoked by unexplained alterations in the bleeding patterns, considerable morbidity is directly attributable to menstrual dysfunction. Aim of the study was to evaluate the efficacy of the Unani formulation as an alternate therapy in the management of Qillat tams. The trial was designed as standard controlled randomized single blind study, conducted in Dept. of Ilmul Qabalat wa Amraze Niswan, National Institute of Unani Medicine hospital, Bangalore. 45 patients were randomly assigned to test (30) and control (15) groups respectively. In test group Unani formulation was given in the form of majoon in a dose of 1 teaspoonful twice daily from 5th to 25th day of cycle for 3 consecutive cycles. In control group Tablet Douluton L once daily was given for the same duration. Subjective parameters i.e. duration of cycle, duration of flow together with objective parameters like pictorial blood loss assessment chart score and body mass index were assessed for improvement. There was a significant improvement in the subjective and objective parameters; test drug was found to be more effective than the control drug in the management of Qillat tams (P < 0.01); results were analyzed using Chi-square test. This study confirms the efficacy of the Unani formulation as an alternate therapy in the management of Qillat tams.